Objective: To observe the efficacy and safety of small doses of aripiprazole in the treatment of attention deficit and hyperactive disorder (ADHD).
2
目的：观察阿立哌唑治疗儿童孤独症和精神发育迟滞的多动及冲动等行为障碍的疗效及不良反应。
Method:Forty-eight children and adolescents diagnosed with autism or mental retardation accompanying with behavior disorder were treated by aripiprazole.
3
齐拉西酮组总不良反应发生率为42.4%，阿立哌唑组总不良反应发生率为57.6%。
The incidence rate of adverse effect is 42.4% in Ziprasidone group and that is 57.6% in Aripiprazole group.
点击反馈